LUCID DIAGNOSTICS INC's ticker is and the CUSIP is 54948X109.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,499 | +9107.9% | 2,991 | +10977.8% | 0.00% | – |
Q2 2023 | $38 | +850.0% | 27 | -99.1% | 0.00% | – |
Q1 2023 | $4 | +33.3% | 3,093 | +20.8% | 0.00% | – |
Q4 2022 | $3 | -100.0% | 2,561 | -64.8% | 0.00% | – |
Q3 2022 | $11,000 | -8.3% | 7,282 | +105.2% | 0.00% | – |
Q1 2022 | $12,000 | +100.0% | 3,548 | +228.2% | 0.00% | – |
Q4 2021 | $6,000 | – | 1,081 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LUMINUS MANAGEMENT LLC | 846,662 | $1,295,000 | 0.45% |
Nantahala Capital Management | 286,432 | $438,000 | 0.03% |
CANTOR FITZGERALD, L. P. | 264,653 | $405,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 185,000 | $283,000 | 0.01% |
KORNITZER CAPITAL MANAGEMENT INC /KS | 133,000 | $203,000 | 0.00% |
Geneos Wealth Management Inc. | 40,850 | $62,000 | 0.00% |
Verition Fund Management LLC | 72,332 | $55,055 | 0.00% |
UBS Group AG | 4,961 | $8,000 | 0.00% |
VANGUARD GROUP INC | 319,366 | $489,000 | 0.00% |
BNP PARIBAS FINANCIAL MARKETS | 973 | $1,489,000 | 0.00% |